𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polyradiculopathy complicating acute lymphoblastic leukemia

✍ Scribed by P. Banerjee; Dr P. K. Maccallum; R. W. H. Walker; T. A. Lister


Book ID
102257999
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
201 KB
Volume
13
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


A patient who presented with a symmetrical polyradiculopathy 6 months before the onset of acute lymphoblastic leukemia (ALL) is described. This case shows that bone marrow aspiration should be considered in such presentations when no other cause has been identified, even if the CSF is not initially diagnostic and the full blood count appears normal.


πŸ“œ SIMILAR VOLUMES


Non-Hodgkin's lymphoma complicating acut
✍ Friedman, Eitan ;Ben-Bassat, Isaac ;Kende, George ;Behar, Albert J. ;Ramot, Brac πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 257 KB

Second malignancies occurring in patients cured of childhood acute lymphoblastic leukemia (ALL) are rare but increasingly recognized. There are only three reported cases of non-Hodgkin's lymphoma complicating ALL in remission. We report here another case of B-cell-type large-cell lymphoma, presentin

Ventral polyradiculopathy with pediatric
✍ Stephen C. Anderson; George D. Baquis; Anthony Jackson; Philip Monteleone; J. Ro πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 239 KB

## Abstract A 3‐year‐old girl with acute lymphocytic leukemia (ALL) in remission developed lower extremity paraparesis and areflexia 15 days after receiving intrathecal methotrexate, cytarabine, and hydrocortisone. Cerebrospinal fluid protein was 107 mg/dl. Compound muscle action potential amplitud

Endocrine complications in pediatric pat
✍ Scott C Howard; Ching-Hon Pui πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 English βš– 240 KB

Endocrine complications of therapy for acute lymphoblastic leukemia (ALL) are common and are potentially debilitating both during and after therapy. Growth velocity slows during therapy for ALL, especially during the first year; however, children who do not receive cranial irradiation usually reach